Registry of stroke cases in Brest
Official title: The Brest Registry of Stroke
Run by University Hospital, Brest · NCT02900521 · Data updated 2026-11-12
This study is collecting information on stroke cases in Brest to see how common strokes are, understand their impact on patients, and find better ways to treat them.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 15 Years and up |
| Sex | All |
| Enrollment | 15000 (estimated) |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 1 site (Brest) |
| Status | Recruiting |
| Started | January 2008 |
| Main results expected | August 2016 |
| Study ends | December 2026 |
| Registry record updated | May 26, 2023 |
| Trial ID | NCT02900521 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged over 15 who have been diagnosed with ischemic stroke, non-traumatic intracranial hematoma, or cerebral venous thrombosis after December 31, 2007, and reside in the defined geographical area.
✕Probably not a fit
Patients under 15 years old or those with unconfirmed diagnoses or specific conditions like aneurysmal subarachnoid hemorrhage will not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Brest Stroke Registry aims to compile all confirmed stroke cases within a specific geographical area to calculate the incidence of strokes. This observational study will gather data on both ischemic and hemorrhagic strokes, focusing on mortality rates in the short and long term. Additionally, it will assess current clinical practices and propose optimal management strategies for stroke patients, aligning with public health initiatives to improve healthcare quality and safety. The registry will also analyze the bleeding risks associated with anticoagulants and anti-platelet agents.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of stroke incidence and mortality, leading to improved management and treatment strategies for stroke patients.
How similar studies have gone: Other similar registries have shown success in improving stroke management and understanding epidemiological trends, indicating that this approach is both tested and valuable.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnostic validated for one of the following pathologies: * Ischemic stroke, * Non-traumatic intracranial hematoma * Cerebral venous thrombosis Diagnostic after December 31, 2007 Age \> 15 years on the date of the diagnostic Patient domiciled at the time of the diagnostic in one of the 79 communes defined beforehand Exclusion Criteria: * Age ≤ 15 years * Validated diagnosis (see below, § 4.2.2) of aneurysmal subarachnoid hemorrhage cerebrovascular * Diagnosis made before 1 January 2008 * Unconfirmed diagnosis * Patient domiciled outside the previously defined area of residence
Where it's running
-
CHRU de Brest
Brest, France Recruiting
Study contacts
- Principal investigator: Serge TIMSIT — CHRU La Cavale Blanche - BREST - FRANCE
- Study coordinator: Serge TIMSIT
- Email: serge.timsit@chu-brest.fr
- Phone: +33298347620
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Best Care for Acute Stroke in General Wards
A nurse-led program called BEST CARE ICTUS_HC is tested in hospitals without Stroke Units to see if it reduces stroke complications and helps recovery after an acute ischemic or hemorrhagic stroke.
-
Heart assessment to check repeat-stroke risk in people with atrial fibrillation
This project will test whether detailed heart examinations can find which people with atrial fibrillation who just had an ischemic stroke are at high risk of having another stroke.
-
Ear-based nerve stimulation to help sleep after a stroke
A device that delivers vagal nerve stimulation through the ear is tested to see if it helps stroke patients in rehab sleep better.
-
Remotely Delivered Step Count Rehab After Stroke
This study tests a remotely guided program that uses step counting and six clinician sessions to see if people who had a stroke can feasibly use it at home.
-
Intra-arterial clot-dissolving treatment for medium-vessel ischemic stroke
The team will test whether giving tenecteplase directly into the artery helps adults with acute ischemic stroke caused by medium-vessel blockage or severe narrowing.
-
Dimephosphon® for recovery after acute ischemic stroke.
This trial will test whether Dimephosphon® given 24–72 hours after stroke onset helps adults with moderate acute ischemic stroke recover better than a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.